- Category
- Small (2024-25)
- Udyam number
- UDYAM-KR-03-0017709

About G7 Synergon Private Limited
Data last updated:
G7 Synergon Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 21 August 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U72200KA2008PTC047522. Its GSTIN is 29AADCG2389J1Z6 (Karnataka). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹12.5 Cr and a paid-up capital of ₹12.01 Cr. It is led by directors Durairaj Sathishkumar and Rajagopal Nandhinidevi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No. 537 9th Cross 5th Main Tatanagar Sahakarnagar, Bangalore, Karnataka, India – 560092.
As per the financials filed for FY 2025, the company reported a revenue of ₹18.97 Cr, a growth of 73% compared to the previous year. For the same year it recorded a net profit of ₹1.43 Cr (net margin 7.5%) and EBITDA of ₹3.31 Cr (EBITDA margin 17.5%). Revenue has grown at a compounded annual rate (CAGR) of 49% over three years and 21% over five years.
The company has about 4 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: G7 Synergon. As per MCA filings, the company has open charges of ₹2.31 Cr on record. Court records list 5 cases involving the company, including 5 filed against it; 1 case is pending.
G7 Synergon Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0017709). The current compliance status is marked as active non-compliant by the Registrar of Companies. For more details, the company can be reached via its website g7synergon.in.
Company details
Recognitions & Rankings of G7 Synergon
Contact details
G7 Synergon Private Limited's registered office is in Bangalore, Karnataka. Its website is g7synergon.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressNo. 537 9th Cross 5th Main Tatanagar Sahakarnagar, Bangalore, Karnataka, India – 560092
- IndustryPharma, Pharma Contract R&D
To see the full contact details of G7 Synergon Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
G7 Synergon operates one associated brand: G7 Synergon. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Biopharmaceutical services including drug discovery research and consulting for healthcare industries in India. | g7synergon.in |
Business activity
The main business activity of G7 Synergon is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of G7 Synergon Private Limited, buy the company report.
Financials of G7 Synergon Private Limited
FY 2025 filings availableG7 Synergon Private Limited reported revenue of ₹18.97 Cr (up 73% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 21% over five years, including 73% growth in the latest year. EBITDA rose 172% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.31 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.43 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.5% | ||||
| Net Profit Margin | 7.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of G7 Synergon Private Limited, buy the company report.
Board of directors of G7 Synergon Private Limited
G7 Synergon has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Durairaj Sathishkumar Also directs: Therapolis Labs LLP, I Botanic Private Limited, Healthchip Technologies Private Limited and 2 more | Director | 30 Dec 2013 | 12 Years 9 Months | Current |
| Rajagopal Nandhinidevi Also directs: Therapolis Labs LLP | Director | 26 Sep 2015 | 11 Years 1 Months | Current |
Peer comparison
G7 Synergon Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medpace Clinical Research India Private Limited | ₹19.34 Cr (FY 2025) | 36.0% | Thane, Maharashtra, India | |||
| G7 Synergon Private Limitedthis company | ₹18.97 Cr (FY 2025) | ₹1.43 Cr | 7.5% | 73.0% | 4 | Bangalore, Karnataka, India |
| Cod Research Private Limited | ₹18.93 Cr (FY 2024) | 244.0% | Ahmedabad, Gujarat, India | |||
| Sci-Tech Centre | ₹18.62 Cr (FY 2025) | -38.0% | Mumbai, Maharashtra, India | |||
| Vipragen Biosciences Private Limited | ₹18.35 Cr (FY 2025) | 46.0% | Mysore, Karnataka, India |
To see the full peer comparison of G7 Synergon Private Limited, buy the company report.
Auditor
G7 Synergon Private Limited is audited by Gowthama and Company for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Gowthama and Company | FY 2023 | 005917S |
Shareholding
The shareholding of G7 Synergon Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of G7 Synergon Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Jan 2025 | 101050141 | Others | ₹2.31 Cr | Open |
Total charge records: 1 View all charges
Legal cases
G7 Synergon Private Limited has 5 court cases on record: 5 filed against it. 1 case is pending and 4 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLAT | 5 | 5 | 1 |
Cases on record (2 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLAT, NCLAT Chennai | Court case (Restoration App) | Filed against the company by an individual | Pending |
| NCLAT, NCLAT Chennai | Interim or miscellaneous application | Filed against the company by an individual | Disposed |
To see the full case history of G7 Synergon Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for G7 Synergon Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
G7 Synergon Private Limited has a workforce of 4 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
GST
G7 Synergon has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AADCG2389J1Z6 | Karnataka | Active | 01 Jul 2017 |
| 33AADCG2389J1ZH | Tamil Nadu | Active | 13 Jan 2022 |
To see the full GST registrations and return filing status of G7 Synergon Private Limited, buy the company report.
Recent activity
G7 Synergon Private Limited has 7 board changes on record since 2013: 2 appointments and 5 cessations. The latest: Rajagopal Nandhinidevi ceased to be Additional Director on 30 Sep 2016.
Frequently asked questions
G7 Synergon is an active private limited company based in Bangalore, Karnataka, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 21 August 2008 (18+ years old) and is registered under CIN U72200KA2008PTC047522.
G7 Synergon has 2 current directors:
- Durairaj Sathishkumar - Director
- Rajagopal Nandhinidevi - Director
The latest financial statements of G7 Synergon on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of G7 Synergon is 29AADCG2389J1Z6, registered in Karnataka. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 33AADCG2389J1ZH (Tamil Nadu).
The CIN (Corporate Identification Number) of G7 Synergon is U72200KA2008PTC047522. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
G7 Synergon has 5 court cases on record: 5 filed against it. 1 is pending.
G7 Synergon was incorporated on 21 August 2008, making it 18+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of G7 Synergon by revenue are Medpace Clinical Research India Private Limited, Cod Research Private Limited, Sci-Tech Centre, Vipragen Biosciences Private Limited, all in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development).
Rajagopal Nandhinidevi ceased to be Additional Director on 30 Sep 2016. Rajagopal Nandhinidevi was appointed as Director on 26 Sep 2015. Durairaj Sathishkumar ceased to be Additional Director on 30 Sep 2014. G7 Synergon has 7 board changes on record in total.
Yes, G7 Synergon is registered as a small enterprise under Udyam registration (number: UDYAM-KR-03-0017709).
G7 Synergon can be reached through the website g7synergon.in. Its registered office is in Bangalore, Karnataka, India.